CVE-2014-7828

Description

FreeIPA 4.0.x before 4.0.5 and 4.1.x before 4.1.1, when 2FA is enabled, allows remote attackers to bypass the password requirement of the two-factor authentication leveraging an enabled OTP token, which triggers an anonymous bind.

Category

3.5
CVSS
Severity: Low
CVSS 2.0 •
EPSS 0.61%
Vendor Advisory fedoraproject.org Vendor Advisory freeipa.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://fedorahosted.org/freeipa/ticket/4690
http://www.freeipa.org/page/Releases/4.1.1 vendor advisory
https://www.redhat.com/archives/freeipa-users/2014-November/msg00077.html mailing list
https://www.redhat.com/archives/freeipa-devel/2014-November/msg00068.html mailing list
https://exchange.xforce.ibmcloud.com/vulnerabilities/98500 vdb entry
http://lists.fedoraproject.org/pipermail/package-announce/2014-November/143000.html vendor advisory
https://bugzilla.redhat.com/show_bug.cgi?id=1160871
http://www.securityfocus.com/bid/70932 vdb entry

Frequently Asked Questions

What is the severity of CVE-2014-7828?
CVE-2014-7828 has been scored as a low severity vulnerability.
How to fix CVE-2014-7828?
To fix CVE-2014-7828, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2014-7828 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2014-7828 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.